Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07104344 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of CM355 in Patients With Systemic Lupus Erythematosus

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status changed: Not Yet Recruiting → Active, Not Recruiting Primary completion date changed from estimate of Apr 2026 to Jun 15, 2026 · Completion pushed from Oct 2026 to Sep 1, 2027 · Eligibility criteria expanded, about 10 words · 1 more Show 4 more changesShow less
    • Primary completion date changed from estimate of Apr 2026 to Jun 15, 2026
    • Completion pushed from Oct 2026 to Sep 1, 2027
    • Eligibility criteria expanded, about 10 words
    • Site contact updated
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study was designed to investigate the safety and efficacy of CM355 in patients with refractory SLE.
Trial Details
NCT Number NCT07104344
Lead Sponsor Second Xiangya Hospital of Central South University
Conditions Systemic Lupus Erythematosus
Enrollment 5 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov